Ruth Koepke1, Michael L Bartholomew2, Jens C Eickhoff3, Roman A Ayele1, Diane Rodd4, Joan Kuennen4, Jean Rosekrans4, David M Warshauer5, James H Conway6, Jeffrey P Davis7. 1. Division of Public Health, Wisconsin Department of Health Services Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison. 2. Division of Public Health, Wisconsin Department of Health Services Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia. 3. Department of Biostatistics and Medical Informatics, School of Medicine and Public Health, University of Wisconsin-Madison. 4. Wood County Health Department, Wisconsin Rapids. 5. Wisconsin State Laboratory of Hygiene, Madison, Wisconsin. 6. Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin-Madison. 7. Division of Public Health, Wisconsin Department of Health Services.
Abstract
BACKGROUND: During October 2011-December 2012, concurrent with a statewide pertussis outbreak, 443 Bordetella parapertussis infections were reported among Wisconsin residents. We examined clinical features of patients with parapertussis and the effect of antibiotic use for treatment and prevention. METHODS: Patients with polymerase chain reaction results positive for B. parapertussis reported during October 2011-May 2012 were interviewed regarding presence and durations of pertussis-like symptoms and receipt of azithromycin treatment. Data regarding acute cough illnesses and receipt of azithromycin prophylaxis among parapertussis patient household members (HHMs) were also collected. Using multivariate repeated measures log-binomial regression analysis, we examined associations of treatment receipt by the HHM with the earliest illness onset and prophylaxis receipt among other HHMs with the presence of any secondary cough illnesses in the household. RESULTS: Among 218 patients with parapertussis, pertussis-like symptoms were frequently reported. Illness durations were significantly shorter among patients with treatment initiated 0-6 days after cough onset, compared with nonrecipients (median durations: 10 vs 19 days, P = .002). Among 361 HHMs from 120 households, compared with nonrecipients, prompt prophylaxis of HHMs was associated with no secondary cough illnesses (relative risk: 0.16; 95% confidence interval, .04-.69). CONCLUSIONS: Bordetella parapertussis infection causes pertussis-like illness that might be misclassified as pertussis if B. parapertussis testing is not performed. Prompt treatment might shorten illness duration, and prompt HHM prophylaxis might prevent secondary illnesses. Further study is needed to evaluate antibiotic effectiveness for preventing parapertussis and to determine risks and benefits of antibiotic use.
BACKGROUND: During October 2011-December 2012, concurrent with a statewide pertussis outbreak, 443 Bordetella parapertussis infections were reported among Wisconsin residents. We examined clinical features of patients with parapertussis and the effect of antibiotic use for treatment and prevention. METHODS:Patients with polymerase chain reaction results positive for B. parapertussis reported during October 2011-May 2012 were interviewed regarding presence and durations of pertussis-like symptoms and receipt of azithromycin treatment. Data regarding acute cough illnesses and receipt of azithromycin prophylaxis among parapertussis patient household members (HHMs) were also collected. Using multivariate repeated measures log-binomial regression analysis, we examined associations of treatment receipt by the HHM with the earliest illness onset and prophylaxis receipt among other HHMs with the presence of any secondary cough illnesses in the household. RESULTS: Among 218 patients with parapertussis, pertussis-like symptoms were frequently reported. Illness durations were significantly shorter among patients with treatment initiated 0-6 days after cough onset, compared with nonrecipients (median durations: 10 vs 19 days, P = .002). Among 361 HHMs from 120 households, compared with nonrecipients, prompt prophylaxis of HHMs was associated with no secondary cough illnesses (relative risk: 0.16; 95% confidence interval, .04-.69). CONCLUSIONS:Bordetella parapertussis infection causes pertussis-like illness that might be misclassified as pertussis if B. parapertussis testing is not performed. Prompt treatment might shorten illness duration, and prompt HHM prophylaxis might prevent secondary illnesses. Further study is needed to evaluate antibiotic effectiveness for preventing parapertussis and to determine risks and benefits of antibiotic use.
Authors: Kathleen M Tatti; Stacey W Martin; Kathryn O Boney; Kristin Brown; Thomas A Clark; Maria Lucia Tondella Journal: Pediatr Infect Dis J Date: 2013-09 Impact factor: 2.129
Authors: Loren Rodgers; Stacey W Martin; Amanda Cohn; Jeremy Budd; Mario Marcon; Andrew Terranella; Sema Mandal; Douglas Salamon; Amy Leber; Maria-Lucia Tondella; Kathleen Tatti; Kevin Spicer; Allen Emanuel; Elizabeth Koch; Londell McGlone; Lucia Pawloski; Mysheika Lemaile-Williams; Naomi Tucker; Radhika Iyer; Thomas A Clark; Mary Diorio Journal: Clin Infect Dis Date: 2012-10-19 Impact factor: 9.079
Authors: P Mastrantonio; P Stefanelli; M Giuliano; Y Herrera Rojas; M Ciofi degli Atti; A Anemona; A E Tozzi Journal: J Clin Microbiol Date: 1998-04 Impact factor: 5.948
Authors: Michael R Weigand; Yanhui Peng; Dhwani Batra; Mark Burroughs; Jamie K Davis; Kristen Knipe; Vladimir N Loparev; Taccara Johnson; Phalasy Juieng; Lori A Rowe; Mili Sheth; Kevin Tang; Yvette Unoarumhi; Margaret M Williams; M Lucia Tondella Journal: mSystems Date: 2019-11-19 Impact factor: 6.496
Authors: Daniela Bottero; María Eugenia Zurita; María Emilia Gaillard; Francisco Carriquiriborde; Pablo Martin Aispuro; Maia Elizagaray; Erika Bartel; Celina Castuma; Daniela Hozbor Journal: Front Immunol Date: 2018-10-29 Impact factor: 7.561